PROMinsight collaborates with numerous organizations worldwide, leveraging a wealth of global expertise in medical and med-tech fields to enhance our portfolio of innovative products.
MRF Rapid Vision
Since partnering in 2024, PROMinsight and MRF Rapid Vision have been working together to transform the landscape of eye health monitoring and treatment. By combining PROMinsight’s expertise in patient-reported outcome measures with MRF Rapid Vision’s innovative home-based vision monitoring solutions, our collaboration aims to provide a comprehensive approach to managing eye diseases.
MRF Rapid Vision’s advanced platform enables patients to monitor conditions such as glaucoma from home, ensuring timely detection and management. This partnership enhances our ability to deliver precise measurements of the impact of eye conditions and treatments from the patient’s perspective, ultimately improving patient outcomes and quality of life.
Together, PROMinsight and MRF Rapid Vision are dedicated to driving advancements in eye health research and offering cutting-edge solutions to healthcare professionals and patients worldwide.
Medtech Actuator
PROMinsight is proud to have participated in the MedTech Actuator Ascend 2023 program, Singapore’s flagship initiative to empower startups with go-to-market strategies and foster connections with like-minded organizations. This partnership has been instrumental in aligning our product offerings with industry needs and identifying synergies with other innovators.
Visibility Scotland
PROMinsight is proud to partner with Visibility Scotland, an organization dedicated to supporting individuals with vision impairment.
With funding from The National Lottery Community Fund Scotland, this collaboration enabled the rollout of the Impact of Vision Impairment for Children (IVI_C) questionnaire on our digital platform during 2022 and 2023. This initiative has helped Visibility Scotland systematically evaluate the effectiveness of their support services for children and young people.
By using the IVI_C questionnaire, they have gained valuable insights to refine existing programs, address areas for improvement, and develop new resources. PROMinsight is honored to support Visibility Scotland in enhancing the quality of life for young individuals with vision impairment through innovative tools and collaborative expertise.
National Health Innovation Centre
PROMinsight is honored to be a portfolio company of the National Health Innovation Centre Singapore (NHIC), a key driver of healthcare innovation in the region. NHIC has been instrumental in supporting our journey, recognizing our potential through their I2D (Innovation to Development), I2A (Innovation to Adoption), and CORE (Commercialisation Readiness) funding awards.
This partnership has not only provided crucial financial backing but has also enabled us to showcase our solutions on prestigious platforms. Over the years, NHIC has facilitated our participation in numerous conferences and exhibitions, connecting us with industry leaders, collaborators, and stakeholders.
NHIC’s unwavering support has empowered PROMinsight to refine our innovations, expand our reach, and accelerate our impact on the healthcare landscape. We are deeply grateful for this partnership and the opportunities it has created to further our mission of transforming healthcare delivery through innovation.
Wilam
PROMinsight is proud to be part of the Wilam Life Sciences Industry Community, a vibrant virtual hub and living database for Australia’s life sciences ecosystem.
This platform has provided us with a unique opportunity to connect with a diverse network of innovators, researchers, and industry leaders across Australia. As members of this dynamic community, we have gained valuable insights into the Australian life sciences landscape and established meaningful collaborations that drive innovation and growth.
Wilam’s commitment to fostering connections and sharing knowledge aligns with our mission to revolutionize healthcare through impactful solutions. We are excited to continue contributing to and benefiting from this thriving community of life sciences pioneers.
APACMed
PROMinsight is proud to be a member of the Asia Pacific Medical Technology Association (APACMed), the leading voice for the medical technology industry in the region.
As an APACMed member, we have access to a collaborative network of industry leaders, innovators, and stakeholders shaping the future of healthcare in Asia Pacific. This membership has provided us with invaluable opportunities to stay informed on industry trends, participate in thought leadership initiatives, and contribute to conversations that advance patient care and medical technology innovation.
Being part of APACMed reinforces our commitment to delivering impactful healthcare solutions and positions PROMinsight as a key player in the dynamic and rapidly evolving medtech ecosystem.
Centre for Eye Research Australia
PROMinsight is honored to collaborate with the Centre for Eye Research Australia (CERA), a global leader in vision science and ophthalmology research.
Through this partnership, PROMinsight’s digital platform supports CERA’s innovative efforts to tackle challenges in vision impairment and eye health. By enhancing the collection and analysis of patient-reported outcomes, we contribute to advancing impactful research and improving clinical care.
Working alongside CERA allows us to play a role in transformative projects that drive progress in eye health. We look forward to continuing this collaboration and making a positive impact on individuals affected by vision impairment.
Singapore Eye Research Institute
PROMinsight is privileged to collaborate with the Singapore Eye Research Institute (SERI), a global leader in ophthalmic and vision research.
As partners, we work closely with SERI to support their mission of advancing eye health through innovative research. By integrating PROMinsight’s digital solutions, SERI has enhanced its ability to collect and analyze patient-reported outcomes, driving insights that improve clinical care and treatment strategies.
This partnership highlights our shared commitment to pushing the boundaries of vision science. Collaborating with SERI allows us to contribute to impactful research that transforms lives and shapes the future of eye health globally.
National University of Singapore
PROMinsight values its collaboration with the National University of Singapore (NUS), a globally renowned institution driving innovation and research excellence.
Partnering with NUS enables us to contribute to cutting-edge research projects and leverage their expertise in healthcare and life sciences. Through this collaboration, we have supported initiatives aimed at advancing patient-reported outcomes, enhancing the understanding of healthcare challenges, and improving clinical practices.
This partnership underscores our commitment to fostering innovation and creating solutions that transform healthcare. Working alongside NUS inspires us to push boundaries and make a meaningful impact in the medical and research communities.
University of Melbourne
PROMinsight is excited to collaborate with the University of Melbourne, a prestigious institution known for its leadership in research and academic excellence.
Through this partnership, we work together to advance healthcare research and clinical practices by leveraging PROMinsight’s digital platform to improve the collection and analysis of patient-reported outcomes. Our collaboration supports the University of Melbourne’s commitment to developing innovative solutions in healthcare, contributing to better patient care and informed decision-making.
We are thrilled to continue working with the University of Melbourne, pushing the frontiers of research and making a meaningful impact on global health challenges.
Flinders University
PROMinsight is honored to collaborate with Flinders University, a leading institution known for its innovation and excellence in healthcare research and education.
This partnership enables us to support Flinders University’s efforts in advancing patient-centered research and improving healthcare outcomes. By integrating PROMinsight’s digital platform, we enhance the university’s ability to collect and analyze patient-reported outcomes, driving valuable insights that inform clinical practices and research initiatives.
We look forward to continuing our collaboration with Flinders University as we work together to create impactful solutions that improve healthcare delivery and contribute to groundbreaking research.
MAPI Research Trust (ePROVIDE)
PROMinsight is excited to be included in the MAPi Research Trust, a global leader in the development and provision of Patient-Reported Outcome Measures (PROMs). Our inclusion in MAPi’s esteemed ePROVIDE database marks a significant milestone in expanding the reach and impact of our PROMs.
By joining ePROVIDE, PROMinsight’s innovative tools are now accessible to a broader network of researchers, clinicians, and healthcare providers, empowering them to utilize reliable, standardized PROMs for better patient care and outcomes. This partnership strengthens our commitment to advancing healthcare research through data-driven insights and improving the quality of patient-centered care.
We look forward to continued collaboration with MAPi Research Trust, supporting the global health community with high-quality PROM solutions that drive meaningful improvements in clinical practice and patient well-being.